Publication | Closed Access

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226

Phase Ib StudyMedicinePharmacologyPathologyAdvanced Solid TumoursPlatinum-doublet ChemotherapyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology